Gracell Biotechnologies Inc (DELISTED) (GRCL:DL)
10.25
0.00 (0.00%)
USD |
NASDAQ |
Feb 22, 16:00
Gracell Biotechnologies Total Liabilities (Quarterly): 36.85M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 36.85M |
| June 30, 2023 | 33.25M |
| March 31, 2023 | 38.23M |
| December 31, 2022 | 40.66M |
| September 30, 2022 | 43.70M |
| June 30, 2022 | 42.58M |
| March 31, 2022 | 41.01M |
| Date | Value |
|---|---|
| December 31, 2021 | 36.52M |
| September 30, 2021 | 34.17M |
| June 30, 2021 | 33.86M |
| March 31, 2021 | 29.42M |
| December 31, 2020 | 22.24M |
| September 30, 2020 | 11.25M |
| December 31, 2019 | 22.42M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
11.25M
Minimum
Sep 2020
43.70M
Maximum
Sep 2022
33.30M
Average
35.35M
Median
Total Liabilities (Quarterly) Benchmarks
| RayzeBio inc (DELISTED) | 28.19M |
| Zai Lab Ltd | 240.18M |
| WuXi Biologics (Cayman) Inc | 1.772B |
| Axonics Inc | 82.36M |
| I-MAB | 146.81M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 259.03M |
| Shareholders Equity (Quarterly) | 222.18M |